Broad Effectiveness: Study With Aripiprazole

Clinical trial NCT00036361 · COMPLETED

Trial details

NCT number: NCT00036361
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2002-07-01
Primary completion: 2003-01-01
Enrollment: 444

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.